Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 291 of 6351
-
Engineered immune cells take on childhood brain cancer in first human trial
Disease control Not yet recruitingThis is a phase I study to assess the safety and feasibility of IL-8 receptor modified patient-derived activated CD70 CAR T cell therapy in newly diagnosed and recurrent CD70+ Pediatric High-Grade Gliomas (pHGG) and Diffuse Intrinsic Pontine Glioma (ndDIPG)
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Brain mets showdown: radiation plus new combo drug tested in lung cancer
Disease control Not yet recruitingThis is a randomized, two-arm, comparative Phase II clinical trial designed to evaluate the difference in intracranial progression-free survival (iPFS) between two treatment strategies, assessed locally. Approximately 158 patients will be randomized in a 1:1 ratio. Will be inclu…
Phase 2 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New radiation trick may spare rectal cancer patients from surgery
Disease control Recruiting nowRectal cancer patients who do not achieve a complete response to standard of care chemotherapy and radiation often require surgical resection as part of curative intent therapy. This study will evaluate whether additional "focal" radiation delivered internally (rectal brachythera…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New cell implant aims to free type 1 diabetes patients from severe hypoglycemia
Disease control Not yet recruitingThis study will evaluate the safety, efficacy and durability of SR-02 administered to the omentum of patients of Type 1 diabetes with severe recurrent hypoglycemia. The study will also help establish the optimal treatment dose. Although this study is open to patients with all HLA…
Phase 1/2 • Sponsor: Seraxis • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a diabetes drug tame the immune system in kidney disease?
Disease control Not yet recruitingWHY IS THIS RESEARCH BEING CONDUCTED? Membranous glomerulonephritis (MN) is an autoimmune disease that affects the kidneys through autoantibodies, meaning that antibodies produced by your body attack your own kidney cells. The appearance of these autoantibodies can be explained i…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New care model aims to close cancer treatment gaps for people with mental illness
Disease control Not yet recruitingThe proposed project is an implementation-effectiveness randomized trial of a person-centered collaborative care model for patients with serious mental illness and new cancer. The BRIDGE NET intervention is theoretically informed, pragmatic, and delivered virtually by an interdis…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
A smartphone camera may help emergency doctors spot severe breathing trouble — a trial puts it to the test
Disease control Not yet recruitingDyspnea is the subjective sensation of difficult or uncomfortable breathing. It accounts for approximately 10% of emergency department visits and 8% of calls to Emergency Medical Communication Centers. Nearly half of patients presenting with dyspnea require hospital admission, 15…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a tiny implant fix a leaky heart valve without open surgery?
Disease control Not yet recruitingA pilot study to evaluate the safety and performance of the MRace System to treat severe mitral regurgitation and to gather data on its performance thereby providing guidance for future clinical development. The study is a single-arm registry with the last follow-up visit at 5 ye…
Sponsor: Polares Medical SA • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a common bile acid pill cut the number of procedures for a precancerous esophagus?
Disease control Not yet recruitingBarrett's esophagus (BE) is a condition in which the normal lining of the esophagus is replaced by abnormal tissue that can increase the risk of esophageal cancer. Endoscopic eradication therapy (EET) removes this abnormal tissue, but most patients need several treatment sessions…
Sponsor: Columbia University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a daily pill keep a rare heart disease in check for the long haul?
Disease control Not yet recruitingThe AG10-504 study is an open-label extension study of acoramidis in participants with newly diagnosed transthyretin amyloid cardiomyopathy (ATTR-CM) or both ATTR-CM and transthyretin amyloid polyneuropathy (ATTR-PN).
Phase 3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a psychedelic help break meth addiction in people with HIV?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether it is possible to use psilocybin in combination with motivational support therapy to treat moderate-to-severe methamphetamine use disorder (MeUD) in people with HIV who are seeking to stop using methamphetamine. The main questio…
Phase 2 • Sponsor: Nicky Mehtani, MD, MPH • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
App alerts when loved ones are near: a new way to fight social isolation in dementia?
Symptom relief Not yet recruitingThis study will evaluate the Social Reminder System, a mobile informatics system designed to support persons with memory concerns and their care partners. The system is intended to aid social integration for persons with memory concerns and improve care coordination and reduce ca…
Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
A personalized support system aims to close cancer care gaps for hispanic patients
Disease control Not yet recruitingThis is a randomized controlled, type 1 hybrid effectiveness-implementation trial to evaluate the effectiveness of a patient-reported outcomes (PRO)-driven culturally grounded supportive care navigation in reducing healthcare disparities among Hispanic/Latinx patients receiving a…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a single lens implant restore near and distance vision?
Disease control Not yet recruitingA prospective, open-labeled, single-site study of a phakic implantable collamer lens (ICL) for the correction/reduction of myopia with or without astigmatism.
Sponsor: Staar Surgical Company • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a prosthetic foot that adapts its stiffness help amputees keep their balance?
Disease control Not yet recruitingThe goal of this clinical trial is to determine if automatic stiffness modulation improves balance control in ambulatory individuals with below-knee amputations in real-world conditions. The main question this clinical trial will answer is: • Can a user-specific automatic stiffn…
Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Hands-On therapy may offer Drug-Free relief for Neck-Linked headaches
Symptom relief Not yet recruitingIntroduction: Cervicogenic headache (CH) is a secondary headache associated with non-traumatic dysfunctions of the cervical region. Osteopathic Care (OC) has shown promising results in reducing pain and disability in patients with migraine, tension-type headaches and CH, but the …
Sponsor: Centro Universitário Augusto Motta • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Can a higher magnesium dose tame severe asthma attacks?
Disease control Not yet recruitingThe goal of this clinical is to compare treatment outcomes between high dose continuous IV Magnesium and standard therapy in the management of acute exacerbation of asthma in the emergency department. Participants will random assign to either high dose continuous IV drip or stand…
Sponsor: Thammasat University • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
A new ultrasound measure may spot At-Risk babies in High-Blood-Pressure pregnancies
Diagnosis Not yet recruitingThe primary aim of this study is to evaluate the predictive value of the Amniotic-Umbilical-to-Cerebral Ratio (AUCR) in predicting composite adverse perinatal outcomes in women with hypertensive disorders of pregnancy and to compare its predictive performance with the traditional…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
Can a new RNA drug tame high blood fats?
Disease control Not yet recruitingEDP167 is a double-stranded small interfering RNA (siRNA) drug targeting angiopoietin-like 3 protein (ANGPTL3), which may bring benefits for patients with dyslipidemia conditions. This Phase 2 clinical study comprises two phases: a randomized, double-blind, placebo parallel-contr…
Phase 2 • Sponsor: Eddingpharm (Zhuhai) Co., Ltd. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a radioactive tracer help surgeons find hidden prostate cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether radioguided surgery can help surgeons find and remove lymph nodes containing prostate cancer in men whose cancer has returned in a small number of lymph nodes after previous prostate cancer treatment. It will also learn about th…
Phase 2 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC